These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 38415671)

  • 41. The role of inhaled opioids and furosemide for the treatment of dyspnea.
    Kallet RH
    Respir Care; 2007 Jul; 52(7):900-10. PubMed ID: 17594733
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacologic Interventions for Breathlessness in Patients With Advanced Cancer: A Systematic Review and Meta-analysis.
    Feliciano JL; Waldfogel JM; Sharma R; Zhang A; Gupta A; Sedhom R; Day J; Bass EB; Dy SM
    JAMA Netw Open; 2021 Feb; 4(2):e2037632. PubMed ID: 33630086
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Benzodiazepines for the relief of breathlessness in advanced malignant and non-malignant diseases in adults.
    Simon ST; Higginson IJ; Booth S; Harding R; Weingärtner V; Bausewein C
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD007354. PubMed ID: 27764523
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Opioids for management of episodic breathlessness or dyspnea in patients with advanced disease.
    Cabezón-Gutiérrez L; Khosravi-Shahi P; Custodio-Cabello S; Muñiz-González F; Cano-Aguirre Mdel P; Alonso-Viteri S
    Support Care Cancer; 2016 Sep; 24(9):4045-55. PubMed ID: 27334130
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Current pharmacological strategies for symptomatic reduction of persistent breathlessness - a literature review.
    Ferreira DH; Kochovska S; McNeill R; Currow DC
    Expert Opin Pharmacother; 2023 Feb; 24(2):233-244. PubMed ID: 36525673
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Opioids, Chronic Obstructive Pulmonary Disease, and Hyperbole.
    Vozoris NT
    J Palliat Med; 2018 Jun; 21(6):745. PubMed ID: 29889015
    [No Abstract]   [Full Text] [Related]  

  • 47. Opioids for chronic refractory breathlessness: patient predictors of beneficial response.
    Johnson MJ; Bland JM; Oxberry SG; Abernethy AP; Currow DC
    Eur Respir J; 2013 Sep; 42(3):758-66. PubMed ID: 23258776
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Opioids for symptomatic therapy of dyspnoea in patients with advanced chronic heart failure--is there evidence?
    Hochgerner M; Fruhwald FM; Strohscheer I
    Wien Med Wochenschr; 2009 Dec; 159(23-24):577-82. PubMed ID: 20151346
    [TBL] [Abstract][Full Text] [Related]  

  • 49. One evidence base; three stories: do opioids relieve chronic breathlessness?
    Ekström M; Bajwah S; Bland JM; Currow DC; Hussain J; Johnson MJ
    Thorax; 2018 Jan; 73(1):88-90. PubMed ID: 28377491
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The dyspnea target: can we zero in on opioid responsiveness in advanced chronic obstructive pulmonary disease?
    Horton R; Rocker G; Currow D
    Curr Opin Support Palliat Care; 2010 Jun; 4(2):92-6. PubMed ID: 20443250
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Opioids for refractory dyspnoea in palliation].
    Aabom B; Bendstrup E; Sjøgren P; Løkke A; Shaker B; Wilcke T; Jespersen BA; Hilberg O; Marsaa K
    Ugeskr Laeger; 2020 Sep; 182(40):. PubMed ID: 33000737
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Refractory Dyspnea in Advanced COPD: Palliative Treatment with Opioids].
    Ficker JH; Brückl WM
    Pneumologie; 2019 Jul; 73(7):430-438. PubMed ID: 31291670
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Oxygen for breathlessness in patients with chronic obstructive pulmonary disease who do not qualify for home oxygen therapy.
    Ekström M; Ahmadi Z; Bornefalk-Hermansson A; Abernethy A; Currow D
    Cochrane Database Syst Rev; 2016 Nov; 11(11):CD006429. PubMed ID: 27886372
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Editor's note: "Effectiveness and safety of opioids on breathlessness and exercise endurance in patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis of randomised controlled trials".
    Palliat Med; 2024 Apr; 38(4):499. PubMed ID: 38456276
    [No Abstract]   [Full Text] [Related]  

  • 55. Benzodiazepines for the relief of breathlessness in advanced malignant and non-malignant diseases in adults.
    Simon ST; Higginson IJ; Booth S; Harding R; Bausewein C
    Cochrane Database Syst Rev; 2010 Jan; (1):CD007354. PubMed ID: 20091630
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In adults with HF, opioids do not reduce refractory breathlessness (low-certainty evidence).
    Khan MS; Van Spall HGC
    Ann Intern Med; 2023 Aug; 176(8):JC88. PubMed ID: 37523697
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Palliation of dyspnoea in advanced COPD: revisiting a role for opioids.
    Rocker G; Horton R; Currow D; Goodridge D; Young J; Booth S
    Thorax; 2009 Oct; 64(10):910-5. PubMed ID: 19786716
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Response to Ekström et al regarding low-dose opioids in advanced chronic obstructive pulmonary disease.
    Vozoris NT
    Evid Based Med; 2015 Feb; 20(1):40. PubMed ID: 25564657
    [No Abstract]   [Full Text] [Related]  

  • 59. The role of benzodiazepines in breathlessness: a single site, open label pilot of sustained release morphine together with clonazepam.
    Allcroft P; Margitanovic V; Greene A; Agar MR; Clark K; Abernethy AP; Currow DC
    J Palliat Med; 2013 Jul; 16(7):741-4. PubMed ID: 23597092
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Testosterone Levels in People Taking Regular Low-Dose Sustained-Release Morphine for Persisting Breathlessness: An Exploratory Study.
    Ferreira DH; Ekström M; Fazekas B; Currow DC
    J Palliat Med; 2023 Mar; 26(3):402-405. PubMed ID: 36394475
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.